Current Pharmaceutical Design
Volume 25, 46 Issues, 2019
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Contents
Current Pharmaceutical Design, Volume 11 - Number 32
Editorial [Hot Topic: Biochemical and Clinical Relevance of Hyperuricaemia (Executive Editor: Dimitri P. Mikhailidis Associate Editor: Stella S. Daskalopoulou)]
, 11(32): 4115 - 4116Stella S. Daskalopoulou and Dimitri P. Mikhailidis
DOI: 10.2174/138161205774913264
Overview of Hyperuricaemia and Gout
, 11(32): 4117 - 4124D. Masseoud, K. Rott, R. Liu-Bryan and C. Agudelo
DOI: 10.2174/138161205774913318
Serum Uric Acid and Risk of Coronary Heart Disease
, 11(32): 4125 - 4132S. G Wannamethee
DOI: 10.2174/138161205774913200
Dietary Factors and Hyperuricaemia
, 11(32): 4133 - 4138Naomi Schlesinger
DOI: 10.2174/138161205774913273
Uric Acid and Oxidative Stress
, 11(32): 4145 - 4151G. K. Glantzounis, E. C. Tsimoyiannis, A. M. Kappas and D. A. Galaris
DOI: 10.2174/138161205774913255
Uric Acid and the Kidney: Urate Transport, Stone Disease and Progressive Renal Failure
, 11(32): 4153 - 4159G. Capasso, Ph. Jaeger, W. G. Robertson and R. J. Unwin
DOI: 10.2174/138161205774913219
Effect on Serum Uric Acid Levels of Drugs Prescribed for Indications other than Treating Hyperuricaemia
, 11(32): 4161 - 4175S. S. Daskalopoulou, V. Tzovaras, D. P. Mikhailidis and M. Elisaf
DOI: 10.2174/138161205774913309
Rasburicase: A New Approach for Preventing and/or Treating Tumor Lysis Syndrome
, 11(32): 4177 - 4185Olga Bessmertny, Lauren M. Robitaille and Mitchell S. Cairo
DOI: 10.2174/138161205774913291
Raloxifene and Cardiovascular Health: Its Relationship to Lipid and Glucose Metabolism, Hemostatic and Inflammation Factors and Cardiovascular Function in Postmenopausal Women
, 11(32): 4187 - 4206Cristiano M Francucci, Andrea Camilletti and Marco Boscaro
DOI: 10.2174/138161205774913237
Recent Advances in the Discovery of Tissue Factor/Factor VIIa Inhibitors and Dual Inhibitors of Factor VIIa/Factor Xa
, 11(32): 4207 - 4227A. Kranjc, D. Kikelj and L. Peterlin-Masic
DOI: 10.2174/138161205774913282
Lifelong Endocrine Fluctuations and Related Cognitive Disorders
, 11(32): 4229 - 4252M. L. Ancelin and K. Ritchie
DOI: 10.2174/138161205774913228
   |
Editor-in-Chief
William A. Banks
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks , who is the current acting Editor-in-Chief since 1995.
Webmaster Contact: info@benthamscience.net